Vgkc is dead: long live lgi1- and caspr2-antibodies. intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies

Vgkc is dead: long live lgi1- and caspr2-antibodies. intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies

Bibliográfalaš dieđut
Váldodahkkit:	Lang, B, Maddison, P, Dettmann, I, Adcock, J, Buckley, C, Leite, I, Vincent, A, Komorowski, L, Waters, P, Irani, S
Materiálatiipa:	Conference item
Giella:	English
Almmustuhtton:	BMJ Publishing Group 2017

Geahča maid

Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
Dahkki: Michael, S, et al.
Almmustuhtton: (2020)

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
Dahkki: Lang, B, et al.
Almmustuhtton: (2017)

LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes
Dahkki: Binks, S, et al.
Almmustuhtton: (2017)

Distinct HLA associations of LGI1 and CASPR2-antibody diseases
Dahkki: Binks, S, et al.
Almmustuhtton: (2018)

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies: Evidence for relative pathogenicity
Dahkki: Lang, B, et al.
Almmustuhtton: (2017)

Magnetic resonance imaging characteristics of LGI1-antibody and CASPR2-antibody encephalitis
Dahkki: Kelly, MJ, et al.
Almmustuhtton: (2024)

Hippocampal epileptogenesis in LGI1, CASPR2 and GABABR antibodies: preliminary findings
Dahkki: Romoli, M, et al.
Almmustuhtton: (2020)

Immunotherapy responsive neuropathic pain associated with LGI1 and CASPR2 antibodies
Dahkki: Ramanathan, S, et al.
Almmustuhtton: (2021)

CXCL13 levels in LGI1-and CASPR2-autoantibody syndromes
Dahkki: Michael, S, et al.
Almmustuhtton: (2019)

The immunogenetics of LGI1- and CASPR2-antibody encephalitis: towards aetiology
Dahkki: Binks, S
Almmustuhtton: (2022)

The distinct pattern of movement disorders in Caspr2 and LGI1 antibody associated autoimmune encephalitis
Dahkki: Goevert, F, et al.
Almmustuhtton: (2019)

Phenotypic Spectrum of CASPR2 and LGI1 Antibodies Associated Neurological Disorders in Children
Dahkki: Yan Jiang, et al.
Almmustuhtton: (2022-04-01)

007 Immunotherapy responsive neuropathic pain associated with LGI1 and CASPR2 antibodies
Dahkki: Russell C Dale, et al.
Almmustuhtton: (2021-08-01)

EEG-confirmed epileptic activity in a cat with VGKC-complex/LGI1 antibody-associated limbic encephalitis.
Dahkki: Pakozdy, A, et al.
Almmustuhtton: (2014)

Suspected limbic encephalitis and seizure in cats associated with voltage-gated potassium channel (VGKC) complex antibody.
Dahkki: Pakozdy, A, et al.
Almmustuhtton: (2013)

Randomized placebo‐controlled trial of intravenous immunoglobulin in autoimmune LGI1/CASPR2 epilepsy
Dahkki: Dubey, D, et al.
Almmustuhtton: (2019)

VGKC-complex antibody encephalitis.
Dahkki: Willis, MD, et al.
Almmustuhtton: (2014)

Caspr2 antibodies in patients with thymomas.
Dahkki: Vincent, A, et al.
Almmustuhtton: (2010)

Hypothermia in VGKC antibody-associated limbic encephalitis.
Dahkki: Jacob, S, et al.
Almmustuhtton: (2008)

The clinical phenotype of non-paraneoplastic voltage gated potassium channel antibody (VGKC Ab) associated CNS disease
Dahkki: Seymour, A, et al.
Almmustuhtton: (2004)

Randomized placebo‐controlled trial of intravenous immunoglobulin in autoimmune LGI1/CASPR2 epilepsy
Dahkki: Dubey, D, et al.
Almmustuhtton: (2019)

Isaacs Syndrome in A Patient with Positive CASPR2 And LGI1 Antibodies: A Case Report and Literature Review
Dahkki: Rasa Zafari, et al.
Almmustuhtton: (2024-04-01)

Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre.
Dahkki: Paterson, R, et al.
Almmustuhtton: (2014)

Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: Experience from a tertiary referral centre
Dahkki: Paterson, R, et al.
Almmustuhtton: (2014)

ANTI-GAD65, NMDAR AND VGKC ANTIBODIES DETECTED IN FIRST EPISODE PSYCHOSIS
Dahkki: Lennox, B, et al.
Almmustuhtton: (2009)

Hemichorea Associated with CASPR2 Antibody
Dahkki: Iryna Vynogradova, et al.
Almmustuhtton: (2014-05-01)

VGKC antibodies in pediatric encephalitis presenting with status epilepticus.
Dahkki: Suleiman, J, et al.
Almmustuhtton: (2011)

Subacute cognitive impairment, hyponatremia and mesial temporal lobe lesions: a typical presentation of voltage-gated potassium channel (VGKC) antibody-associated limbic encephalitis
Dahkki: Thais Saccardi, et al.
Almmustuhtton: (2011-12-01)

N-Methyl-D-Aspartate(NMDA) Receptor and Voltage-Gated Potassium Channel (VGKC) Antibody-Associated Encephalitides Presenting as First Episode Acute Psychosis
Dahkki: Charmaine Tang, et al.
Almmustuhtton: (2019-12-01)

Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies.
Dahkki: Pellkofer, H, et al.
Almmustuhtton: (2010)

Reply to: Hemichorea Associated with CASPR2 Antibody
Dahkki: Ritesh A. Ramdhani, et al.
Almmustuhtton: (2014-05-01)

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.
Dahkki: Irani, SR, et al.
Almmustuhtton: (2011)

Lack of antibodies to NMDAR or VGKC-complex in GAD and cardiolipin antibody-positive refractory epilepsy.
Dahkki: Liimatainen, S, et al.
Almmustuhtton: (2014)

LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
Dahkki: Jang, Y, et al.
Almmustuhtton: (2018)

Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis.
Dahkki: Tofaris, G, et al.
Almmustuhtton: (2012)

LGI1 and CASPR2-related Morvan syndrome - diagnostic challenges in a pediatric case
Dahkki: Elena Catalina Petrov, et al.
Almmustuhtton: (2023-06-01)

Relative frequency of VGKC and 'classical' paraneoplastic antibodies in patients with limbic encephalitis.
Dahkki: Jarius, S, et al.
Almmustuhtton: (2008)

Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity.
Dahkki: Malter, M, et al.
Almmustuhtton: (2014)

CASPR2 antibody associated neurological syndromes in children
Dahkki: Liwen Wu, et al.
Almmustuhtton: (2023-02-01)

Cognitive, neuropsychiatric and quality-of-life sequelae in LGI1-antibody disease demonstrates fatigue as the key determinant of wellbeing
Dahkki: Binks, S, et al.
Almmustuhtton: (2020)